Verve Therapeutics Inc (VERV)
6.155
-0.06
(-1.05%)
USD |
NASDAQ |
Apr 26, 16:00
6.155
0.00 (0.00%)
After-Hours: 18:24
Verve Therapeutics Market Cap: 514.68M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 520.11M |
| April 24, 2024 | 550.22M |
| April 23, 2024 | 575.30M |
| April 22, 2024 | 577.81M |
| April 19, 2024 | 555.23M |
| April 18, 2024 | 556.90M |
| April 17, 2024 | 563.59M |
| April 16, 2024 | 597.04M |
| April 15, 2024 | 611.26M |
| April 12, 2024 | 635.51M |
| April 11, 2024 | 674.81M |
| April 10, 2024 | 669.79M |
| April 09, 2024 | 731.67M |
| April 08, 2024 | 702.40M |
| April 05, 2024 | 712.44M |
| April 04, 2024 | 725.82M |
| April 03, 2024 | 728.32M |
| April 02, 2024 | 695.71M |
| April 01, 2024 | 1.069B |
| March 28, 2024 | 1.110B |
| March 27, 2024 | 1.103B |
| March 26, 2024 | 1.069B |
| March 25, 2024 | 1.100B |
| March 22, 2024 | 1.085B |
| March 21, 2024 | 1.105B |
| Date | Value |
|---|---|
| March 20, 2024 | 1.119B |
| March 19, 2024 | 1.088B |
| March 18, 2024 | 1.113B |
| March 15, 2024 | 1.155B |
| March 14, 2024 | 1.137B |
| March 13, 2024 | 1.199B |
| March 12, 2024 | 1.164B |
| March 11, 2024 | 1.206B |
| March 08, 2024 | 1.251B |
| March 07, 2024 | 1.249B |
| March 06, 2024 | 1.260B |
| March 05, 2024 | 1.266B |
| March 04, 2024 | 1.325B |
| March 01, 2024 | 1.362B |
| February 29, 2024 | 1.426B |
| February 28, 2024 | 1.502B |
| February 27, 2024 | 1.467B |
| February 26, 2024 | 1.207B |
| February 23, 2024 | 1.125B |
| February 22, 2024 | 1.114B |
| February 21, 2024 | 1.098B |
| February 20, 2024 | 1.092B |
| February 16, 2024 | 1.073B |
| February 15, 2024 | 1.089B |
| February 14, 2024 | 1.045B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
514.68M
Minimum
Apr 26 2024
3.551B
Maximum
Sep 10 2021
1.417B
Average
1.206B
Median
Market Cap Benchmarks
| Acorda Therapeutics Inc | 0.9068M |
| Eli Lilly and Co | 697.22B |
| Intellia Therapeutics Inc | 1.996B |
| Beam Therapeutics Inc | 1.746B |
| Gritstone Bio Inc | 80.85M |
Market Cap Related Metrics
| PS Ratio | 35.19 |
| Price to Book Value | 0.8585 |
| Price | 6.155 |
| Earnings Yield | -50.69% |